The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period

The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period

<p>Abstract</p> <p>Background</p> <p>Obesity, type 2 diabetes mellitus (T2D) and unhealthy blood lipid profile are strongly associated with the risk of developing cardiovascular disease (CVD). We examined whether blood lipid changes with short term administration of the...

Full description

Bibliographic Details
Main Authors: James Philip T, Finer Nick, Sharma Arya M, Køber Lars, Brendorp Bente, Fosbøl Emil L, Andersson Charlotte, Weeke Peter, Caterson Ian D, Rode Richard A, Torp-Pedersen Christian
Format: Article
Language:English
Published: BMC 2010-02-01
Series:BMC Endocrine Disorders
Online Access:http://www.biomedcentral.com/1472-6823/10/3

Internet

http://www.biomedcentral.com/1472-6823/10/3

Similar Items